drugdeliverybusiness4d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Medtronic Falls 4.5% Pre-Market After Mixed Q3 Earnings, Full-Year Guidance Reaffirmed
Despite maintaining its full-year outlook, Medtronic slips in pre-market trading following a revenue miss in its Q3 report.
Medscape4d
Medtronic Warns About Insulin Pump Action During Air Travel
Medtronic has issued an “Urgent Medical Device Correction” about the accuracy of insulin pump delivery during changes in air pressure, such as airplane takeoffs and landings. “We request you ...
Medtronic Earnings Review: Stuck In The Single Digits Again
Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.
Medtronic’s stock drops on inventory hiccup and revenue miss
Medtronic PLC’s stock fell 7.3% as the worst performer in the S&P 500 on Tuesday after the medical-products company’s ...
MassDevice4d
Medtronic slightly misses on revenue in Q3
Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast
Medtronic Plc (NYSE:MDT) reported third-quarter 2025 sales of $8.29 billion, missing the consensus of $8.32 billion. The ...
Medtronic expects pressure in surgical unit for fourth quarter, shares fall
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...